Eagle Global Advisors LLC Reduces Stake in CVS Health (CVS)

Eagle Global Advisors LLC lowered its stake in shares of CVS Health (NYSE:CVS) by 49.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 62,585 shares of the pharmacy operator’s stock after selling 60,494 shares during the period. Eagle Global Advisors LLC’s holdings in CVS Health were worth $4,537,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Fort L.P. increased its position in shares of CVS Health by 53.5% during the fourth quarter. Fort L.P. now owns 259,948 shares of the pharmacy operator’s stock worth $18,846,000 after acquiring an additional 90,592 shares in the last quarter. Carnegie Capital Asset Management LLC increased its position in shares of CVS Health by 266.3% during the fourth quarter. Carnegie Capital Asset Management LLC now owns 41,308 shares of the pharmacy operator’s stock worth $3,034,000 after acquiring an additional 30,032 shares in the last quarter. Doliver Capital Advisors LP bought a new stake in shares of CVS Health during the fourth quarter worth about $210,000. Van Hulzen Asset Management LLC bought a new stake in shares of CVS Health during the fourth quarter worth about $500,000. Finally, First City Capital Management Inc. increased its position in shares of CVS Health by 12.3% during the fourth quarter. First City Capital Management Inc. now owns 19,202 shares of the pharmacy operator’s stock worth $1,392,000 after acquiring an additional 2,100 shares in the last quarter. Hedge funds and other institutional investors own 83.97% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other news, EVP Helena Foulkes sold 19,965 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the completion of the transaction, the executive vice president now directly owns 65,072 shares of the company’s stock, valued at approximately $4,622,714.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.61% of the stock is owned by corporate insiders.



Several research firms have recently commented on CVS. Needham & Company LLC raised shares of CVS Health from a “buy” rating to a “strong-buy” rating and boosted their target price for the stock from $88.00 to $100.00 in a research report on Tuesday, January 30th. Mizuho set a $95.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Cowen reaffirmed an “outperform” rating and issued a $99.00 price objective (up from $81.00) on shares of CVS Health in a research report on Thursday, January 18th. Vetr downgraded shares of CVS Health from a “hold” rating to a “sell” rating and set a $76.66 price objective for the company. in a research report on Tuesday, January 16th. Finally, ValuEngine downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $86.65.

CVS Health stock opened at $65.86 on Friday. CVS Health has a twelve month low of $60.14 and a twelve month high of $84.00. The company has a market cap of $68,085.24, a PE ratio of 11.16, a P/E/G ratio of 1.11 and a beta of 1.05. The company has a quick ratio of 0.52, a current ratio of 1.02 and a debt-to-equity ratio of 0.59.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.88 by $0.04. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm had revenue of $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. During the same period in the prior year, the firm earned $1.71 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. equities analysts expect that CVS Health will post 6.3 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 3rd. Stockholders of record on Monday, April 23rd will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.04%. The ex-dividend date is Friday, April 20th. CVS Health’s dividend payout ratio is currently 33.90%.

TRADEMARK VIOLATION WARNING: “Eagle Global Advisors LLC Reduces Stake in CVS Health (CVS)” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2018/04/20/eagle-global-advisors-llc-reduces-stake-in-cvs-health-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply